Professional Documents
Culture Documents
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
Pain Control Administer undiluted
May be diluted in D5W or 0.9% NaCl
RATE:
Slowly over 1-3 min. Doses >5mcg/kg should be given
over 5-10 min.
Mechanism of action and indications Nursing Implications (what to focus on)
(Why med ordered) Contraindications/warnings/interactions
Binds to opiate receptors in the CNS, altering the Hypersensitivity to fentnyl. Known intolerance. Acute
response to and perception of pain. Decrease in severity pain. Alcohol intolerance. USE CAUTIOUSLY in patients
of chronic pain > 60 yrs old, cachectic or debilitated patients; undiagnosed
abdominal pain, hypothyroidism.
Common side effects
CNS: confusion, sedation, weakness, dizziness,
laryngospasm, respiratory depression. CV: bradycardia.
RESP: apnea, bronchoconstricion, laryngospasm,
respiratory depression. GI: anorexia, constipation, dry
mouth, nausea, vomiting. DERM: sweating, erythema.
LOCAL: application site reactions. MS: skeletal and
thoracic muscle rigidity. MISC: physical dependence,
psychological dependence.
Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine
medicines (ask patient specifically) May increase plasma amylase and lipase levels.
Increased CNS and respiratory depression with
Be sure to teach the patient the following about this
sedative/hypnotics.
medication
Instruct patient how and when to ask for pain medication.
Instruct patient on correct application and disposal of
patches. May be worn while bathing showering or
swimming. May cause drowsiness or dizziness. Call for
assist with ambulating. Chang positions slowly to minimize
dizziness. Avoid use of alcohol. Good oral hygiene.
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this Check after giving
Assess type location and intensity of pain med? Evaluate level of pain 24 hr
before application. Assess vital signs before Respiratory rate <10/min, bradycardia after application and
application. periodically during treatmet.